SCHEMBL6090261

SCHEMBL6090261

Nc1nc(-c2cccnc2)nc2c[c]ccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44
CYP1A2 P05177 6/20 0.43
CYP3A4 P08684 6/20 0.43
CLK4 Q9HAZ1 5/20 0.43
TSHR P16473 5/20 0.43
CYP2D6 P10635 4/20 0.43
ALDH1A1 P00352 4/20 0.43
HSD17B10 Q99714 4/20 0.43
CYP2C19 P33261 3/20 0.43
CYP2C9 P11712 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GLA P06280 1/20 0.43
LMNA P02545 5/20 0.42
POLB P06746 3/20 0.42
MAPT P10636 3/20 0.42
NPSR1 Q6W5P4 2/20 0.42
USP2 O75604 2/20 0.42
SMN1; SMN2 Q16637 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30843879 0.81 CYP1A2 (0.62) CYP1A2CYP3A4CLK4TSHRCYP2D6
SCHEMBL30804557 0.81 CYP1A2 (0.62) CYP1A2CYP3A4CLK4TSHRCYP2D6
SCHEMBL29650643 0.81 MAPT (0.49) ADORA2AADORA1CYP1A2CYP3A4CLK4
SCHEMBL13272569 0.81 CYP1A2 (0.62) CYP1A2CYP3A4CLK4TSHRCYP2D6
Hydrochloric Acid SCHEMBL11861199 0.80 CYP1A2 (0.61) CYP1A2CYP3A4CLK4TSHRCYP2D6
SCHEMBL6091929 0.78 ADORA2A (0.38) ADORA2AADORA1CYP1A2NPC1RAB9A
SCHEMBL8218589 0.75 KDM4E (0.49) ADORA2AALDH1A1HSD17B10MEN1KMT2A
SCHEMBL14727632 0.75 CYP1A2 (0.50) ADORA2AADORA1CYP1A2CYP3A4CLK4
SCHEMBL29859473 0.73 SMN1; SMN2 (0.57) ADORA2AADORA1CYP1A2CYP3A4TSHR
SCHEMBL20273560 0.72 ADORA2A (0.49) ADORA2AADORA1CYP1A2CYP3A4CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7005435-B2 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2006-02-28 US disclosed